Natco Pharma gains on reporting around 3-fold jump in Q4 consolidated net profit

31 May 2017 Evaluate

Natco Pharma is currently trading at Rs. 946.55, up by 6.90 points or 0.73% from its previous closing of Rs. 939.65 on the BSE.

The scrip opened at Rs. 948.90 and has touched a high and low of Rs. 966.65 and Rs. 935.00 respectively. So far 29487 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1015.00 on 18-Apr-2017 and a 52 week low of Rs. 471.85 on 02-Jun-2016.

Last one week high and low of the scrip stood at Rs. 966.65 and Rs. 875.00 respectively. The current market cap of the company is Rs. 16439.84 crore.

The promoters holding in the company stood at 51.24%, while institutions and non-institutions held 26.70% and 22.05% respectively.

Natco Pharma has reported has posted over 2-fold jump in its net profit after tax at Rs 177.30 crore for the quarter ended March 31, 2017 as compared to Rs 69 crore for the same quarter in the previous year. Total income of the company increased by 41.09% at Rs 554.50 crore for quarter under review as compared to Rs 393 crore for the quarter ended March 31, 2016. 

On consolidated basis, the company has posted around 3-fold jump in its net profit at Rs 176.40 crore for the quarter ended March 31, 2017 as compared to Rs 63 crore for the same quarter in the previous year. Total income of the company increased by 46.20% at Rs 577.20 crore for quarter under review as compared to Rs 394.80 crore for the same quarter ended previous year. 

For the year ended March 31, 2017, the company has posted around 3-fold jump in its net profit at Rs 494.80 crore as compared to Rs 176.50 crore in FY16. Total income of company increased by 88.04% at Rs 2016 crore for year under review as compared to Rs 1072.10 crore for the year ended March 31, 2016.

For the year ended March 31, 2017, on the consolidated basis, the company has posted over 3-fold jump in its net profit at Rs 484.90 crore as compared to Rs 155.80 crore in the previous year. Total income of the company increased by 90.78% at Rs 2078.90 crore for year under review as compared to Rs 1089.70 crore for the year ended March 31, 2016.

Natco Pharma Share Price

895.70 7.10 (0.80%)
02-Jan-2026 15:46 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1730.30
Dr. Reddys Lab 1255.45
Cipla 1511.70
Zydus Lifesciences 917.00
Lupin 2108.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×